Skip to main content

UBS Group AG

Position in FBRX — Forte Biosciences, Inc.

CIK 1610520 ZURICH, V8

Position in FBRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,496,835
+$2,967,181 QoQ
Shares Held
164,557
+704.7% QoQ
Ownership
0.775%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#27
of 85 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. FBRX ranks #167 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FBRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,496,835 164,557
2026-03-31 $529,654 20,450
2025-12-31 $676,949 24,824
2025-09-30 $23,400 1,560
2025-06-30 $12 1
2025-03-31 $4,089 527
2024-09-30 $8,976 1,606
2024-06-30 $13,053 24,310
2024-03-31 $22 33
2023-12-31 $119 146
2023-09-30 $1,634 2,471
2023-06-30 $34 33
2023-03-31 $9,614 9,520
2022-12-31 $1,715 1,715
2022-09-30 $35 33
2022-06-30 $2,458 1,892
2022-03-31 $3,168 2,171
2021-12-31 $24,642 11,515
2021-09-30 $888 300
2021-06-30 $20,911 622
2021-03-31 $10,281 300
2020-12-31 $25,487 700
2020-09-30 $33,083 682
2020-03-31 TOCA 20,972